These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 21080596)
41. The CD3- 16+ 56+ NK cell count independently predicts autologous blood stem cell mobilization. Stewart DA; Guo D; Luider J; Auer I; Klassen J; Morris D; Brown CB; Chaudhry A; Glück S; Russell JA Bone Marrow Transplant; 2001 Jun; 27(12):1237-43. PubMed ID: 11548841 [TBL] [Abstract][Full Text] [Related]
42. Day +100 Platelet Count Predicts Survival After Allogeneic Hematopoietic Stem-Cell Transplantation in Children With Hematologic Malignancies. Moneib H; Hafez H; Abdalla A; Hassanain O; Lehmann L; Haddad AE Clin Lymphoma Myeloma Leuk; 2019 May; 19(5):e221-e227. PubMed ID: 30846344 [TBL] [Abstract][Full Text] [Related]
43. The relationship between circulating natural killer cells after reduced intensity conditioning hematopoietic stem cell transplantation and relapse-free survival and graft-versus-host disease. Dunbar EM; Buzzeo MP; Levine JB; Schold JD; Meier-Kriesche HU; Reddy V Haematologica; 2008 Dec; 93(12):1852-8. PubMed ID: 18945751 [TBL] [Abstract][Full Text] [Related]
44. Prediction of engraftment after peripheral blood stem cell transplantation by CD34-positive cells in grafts. Urashima M; Uchiyama H; Hoshi Y; Deguchi Y; Kamijou M; Katou Y; Fujisawa K; Akatsuka J; Maekawa K Acta Paediatr Jpn; 1993 Aug; 35(4):325-31. PubMed ID: 7691026 [TBL] [Abstract][Full Text] [Related]
45. Infused Autograft Absolute Lymphocyte Count Predicts Superior Survival in Diffuse Large B Cell Lymphoma Patients Post-Autologous Peripheral Blood Hematopoietic Stem Cell Transplantation: A Matched Case-Control Study. Porrata LF; Burgstaler EA; Winters JL; Jacob E; Inwards DJ; Ansell SM; Micallef IN; Johnston PB; Villasboas J; Paludo J; Markovic SN Transplant Cell Ther; 2021 Sep; 27(9):769.e1-769.e8. PubMed ID: 34091071 [TBL] [Abstract][Full Text] [Related]
46. Daily measurements of blood CD34+ cells after stem cell mobilization predict stem cell yield and posttransplant hematopoietic recovery. Remes K; Matinlauri I; Grenman S; Itälä M; Kauppila M; Pelliniemi TT; Salminen E; Vanharanta R; Rajamäki A J Hematother; 1997 Feb; 6(1):13-9. PubMed ID: 9112214 [TBL] [Abstract][Full Text] [Related]
47. Low baseline platelet count predicts poor response to plerixafor in patients with multiple myeloma undergoing autologous stem cell mobilization. Bakeer M; Zubair AC; Roy V Cytotherapy; 2020 Jan; 22(1):16-20. PubMed ID: 31879152 [TBL] [Abstract][Full Text] [Related]
48. [Factors influencing successful isolation of mesenchymal stem cells from human umbilical cord blood]. Luo F; Yang YJ; Wang X; Yu XH; Wang QH; Song JH; Liu CT; Huang R Zhonghua Er Ke Za Zhi; 2006 Jul; 44(7):509-12. PubMed ID: 17044976 [TBL] [Abstract][Full Text] [Related]
49. Assessment of haematopoietic progenitor cell counting with the Sysmex Dima F; Barison E; Midolo M; Benedetti F; Lippi G Blood Transfus; 2020 Jan; 18(1):67-76. PubMed ID: 31403932 [TBL] [Abstract][Full Text] [Related]
50. The effect of freezing on the recovery and expansion of umbilical cord blood hematopoietic stem cells. Beshlawy AE; Metwally HG; Khalek KA; Hammoud RF; Mousa SM Exp Clin Transplant; 2009 Mar; 7(1):50-5. PubMed ID: 19364313 [TBL] [Abstract][Full Text] [Related]
51. Blood stem cell collections in multiple myeloma: definition of a scoring system. Corso A; Caberlon S; Pagnucco G; Klersy C; Zappasodi P; Alessandrino EP; Vanelli L; Mangiacavalli S; Lazzarino M; Bernasconi C Bone Marrow Transplant; 2000 Aug; 26(3):283-6. PubMed ID: 10967566 [TBL] [Abstract][Full Text] [Related]
52. [Transplantation of umbilical cord mesenchymal stem cells combined with haploidentical hematopoietic stem cells for 36 patients with refractory/relapsed myeloid leukemia]. Wu YM; Cao YB; Li XH; Xu LX; Liu ZY; Liu B; Yan B; Yang XL; Li SW; DA WM; Gao CJ; Wu XX Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Aug; 22(4):1053-7. PubMed ID: 25130827 [TBL] [Abstract][Full Text] [Related]
53. Effects of telomerase and telomere length on epidermal stem cell behavior. Flores I; Cayuela ML; Blasco MA Science; 2005 Aug; 309(5738):1253-6. PubMed ID: 16037417 [TBL] [Abstract][Full Text] [Related]
54. Double-cycle high-dose chemotherapy with peripheral blood stem cells and hematopoietic growth factor support in patients with advanced solid tumor. A pilot study by the Hong Kong Biotherapy Group. Yeung AW; Pang YK; Tsang YC; Wong SW Cancer; 1994 Apr; 73(7):1960-70. PubMed ID: 7511042 [TBL] [Abstract][Full Text] [Related]
55. [Screening test for hematopoietic stem cells in umbilical cord blood by automated hematology analyzer, SE-9000]. Sasaki H; Watanabe S Rinsho Byori; 1999 May; Suppl 110():131-3. PubMed ID: 10475042 [TBL] [Abstract][Full Text] [Related]
56. [Features of chronic myeloid leukemia at diagnosis. Study of a series of 134 cases]. Jonte F; Barez A; Soto I; Rayón C; Carrera D; Coma A; Pérez Llanderal J; Arribas M Sangre (Barc); 1992 Oct; 37(5):345-50. PubMed ID: 1293773 [TBL] [Abstract][Full Text] [Related]
57. Increment of hematopoietic progenitor cell count as an indicator of efficient autologs stem cell harvest in patients with multiple myeloma. Jo JC; Yoon DH; Kim S; Jang S; Park CJ; Chi HS; Park CS; Huh J; Lee SW; Suh C J Clin Apher; 2012 Nov; 27(5):229-34. PubMed ID: 22535685 [TBL] [Abstract][Full Text] [Related]
58. The absolute number of circulating CD34+ cells as the best predictor of peripheral hematopoietic stem cell yield. Fontão-Wendel R; Lazar A; Melges S; Altobeli C; Wendel S J Hematother; 1999 Jun; 8(3):255-62. PubMed ID: 10417048 [TBL] [Abstract][Full Text] [Related]
59. Bone healing and migration of cord blood-derived stem cells into a critical size femoral defect after xenotransplantation. Jäger M; Degistirici O; Knipper A; Fischer J; Sager M; Krauspe R J Bone Miner Res; 2007 Aug; 22(8):1224-33. PubMed ID: 17451370 [TBL] [Abstract][Full Text] [Related]
60. Improved Prediction of CD34+ Cell Yield before Peripheral Blood Hematopoietic Progenitor Cell Collection Using a Modified Target Value-Tailored Approach. Sheppard D; Tay J; Palmer D; Xenocostas A; Doulaverakis C; Huebsch L; McDiarmid S; Tinmouth A; Mallick R; Martin L; Birch P; Hamelin L; Allan D; Bredeson C Biol Blood Marrow Transplant; 2016 Apr; 22(4):763-767. PubMed ID: 26643030 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]